Live Breaking News & Updates on Rhonda Farnum

Stay updated with breaking news from Rhonda farnum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Theravance Biopharma, Inc. (NASDAQ:TBPH) Q3 2023 Earnings Call Transcript

Theravance Biopharma, Inc. (NASDAQ:TBPH) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Ladies and gentlemen, good afternoon. I’d like to welcome everyone to Theravance Biopharma’s Third Quarter 2023 Conference Call. During the presentation, all participants will be in a listen-only mode. A question-and-answer session will follow the company’s formal remarks. [Operator Instructions] Also, today’s […] ....

Theravance Biopharma , Rick Winningham , Rhonda Farnum , Aziz Sawaf , Semiconductor Stocks To Buy , Gold Report , Semiconductor Stocks To Buy Now , Electric Utility Stocks To Buy , Dick Graham , Rick Winningham , Rhonda Farnum , Pet Sales ,

Martingale Asset Management L P Invests $682,000 in Theravance Biopharma, Inc. (NASDAQ:TBPH)

Martingale Asset Management L P acquired a new position in Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Rating) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 60,742 shares of the biopharmaceutical company’s stock, valued at approximately $682,000. Martingale Asset Management L […] ....

Richarda Graham , Rhonda Farnum , Theravance Biopharma , Theravance Biopharma Inc , Acadian Asset Management , Exchange Commission , Royal Bank , Securities Exchange Commission , Get Rating , Capital Management , Asset Management , Biopharma Stock Down , Visit Holdingschannel , Theravance Biopharma Daily , Nasdaq Tbph , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Opaleye Management Inc. Takes Position in Theravance Biopharma, Inc. (NASDAQ:TBPH)

Opaleye Management Inc. acquired a new stake in shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Rating) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 87,600 shares of the biopharmaceutical company’s stock, valued at approximately $983,000. Opaleye Management […] ....

Richarda Graham , Theravance Biopharma , Rhonda Farnum , Exchange Commission , Swiss National Bank , Securities Exchange Commission , Theravance Biopharma Inc , Allspring Global Investments Holdings , Opaleye Management Inc , Group Plc , Acadian Asset Management , Opaleye Management , Get Rating , General Group Plc , Global Investments Holdings , Asset Management , National Bank , Visit Holdingschannel , Theravance Biopharma Daily , Nasdaq Tbph , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,